Understanding how T cells recognize the SARS-CoV-2 virus
Structural Basis for T Cell Recognition of SARS-CoV-2
This study is looking at how a type of immune cell called T cells recognizes and fights the virus that causes COVID-19, with the goal of helping to make vaccines even better for everyone.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Maryland, College Park NIH-funded |
| Lab location | 1 site (College Park, United States) |
| Project ID | NIH-10898547 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which T cells recognize and respond to the SARS-CoV-2 virus, which causes COVID-19. The study aims to obtain detailed structural information about T cell receptors (TCRs) and their interactions with viral proteins presented by immune cells. By focusing on CD8+ T cells, which are crucial for clearing the virus, the research seeks to enhance our understanding of the immune response and improve vaccine efficacy. This work will involve advanced techniques such as crystallography to visualize these interactions at the atomic level.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have recovered from COVID-19 and have developed a T cell response to the virus.
Not a fit: Patients who have not been infected with SARS-CoV-2 or those with compromised immune systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and therapies for COVID-19 by enhancing our understanding of T cell immunity.
How similar studies have performed: Other research has shown success in understanding antibody responses to SARS-CoV-2, but this specific focus on T cell recognition is relatively novel.
Where this research is happening
College Park, United States
- Univ of Maryland, College Park — College Park, United States (Active)
Researchers
- Principal investigator: Mariuzza, Roy a — Univ of Maryland, College Park
- Study coordinator: Mariuzza, Roy a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.